Icon (ICLR) Total Current Liabilities (2009 - 2026)
Icon's (ICLR) quarterly Total Current Liabilities came in at $3.9 billion in Q2 2026, up 53.88% year-over-year from $2.6 billion in Q2 2025, and up 24.14% quarter-over-quarter from $3.2 billion in Q1 2026.
Analysis
Icon (ICLR) Total Current Liabilities (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Total Current Liabilities for 18 consecutive years, with $3.9 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Current Liabilities rose 53.88% year-over-year to $3.9 billion in Q2 2026; TTM through Jun 2026 was $3.9 billion, a 53.88% increase from a year earlier, with the FY2025 full-year figure at $3.2 billion, up 15.68% from the prior year.
- Total Current Liabilities was $3.9 billion for Q2 2026 at Icon, up from $3.2 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $3.9 billion in Q2 2026 and troughed at $2.5 billion in Q2 2022.
- A 5-year average of $2.9 billion and a median of $2.8 billion in 2023 frame the typical range for Total Current Liabilities.
- The widest YoY moves for Total Current Liabilities: up 124.59% in 2022, down 70.74% in 2022.
- Over 5 years, Total Current Liabilities stood at $2.9 billion in 2022, then declined by 6.81% to $2.7 billion in 2023, then increased by 1.2% to $2.8 billion in 2024, then climbed by 15.68% to $3.2 billion in 2025, then grew by 23.11% to $3.9 billion in 2026.
- The last three Total Current Liabilities figures came in at $3.9 billion (Q2 2026), $3.2 billion (Q1 2026), and $3.2 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 8.82 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.44 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 3.93 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.13 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 963.70 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 363.19 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 72.74 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 18.73 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 4.76 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 1.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.93 Bn |
| Mar 31, 2026 | 3.17 Bn |
| Dec 31, 2025 | 3.20 Bn |
| Sep 30, 2025 | 3.22 Bn |
| Jun 30, 2025 | 2.56 Bn |
| Mar 31, 2025 | 2.69 Bn |
| Dec 31, 2024 | 2.76 Bn |
| Sep 30, 2024 | 2.82 Bn |
| Jun 30, 2024 | 2.74 Bn |
| Mar 31, 2024 | 2.64 Bn |
| Dec 31, 2023 | 2.73 Bn |
| Sep 30, 2023 | 2.87 Bn |
| Jun 30, 2023 | 2.76 Bn |
| Mar 31, 2023 | 2.90 Bn |
| Dec 31, 2022 | 2.93 Bn |
| Sep 30, 2022 | 2.73 Bn |
| Jun 30, 2022 | 2.48 Bn |
| Mar 31, 2022 | 2.54 Bn |
| Dec 31, 2021 | 2.64 Bn |
| Sep 30, 2021 | 2.30 Bn |